Axillary lymph node metastasis in recurrence of papillary thyroid carcinoma: A case report

Wiener Klinische Wochenschrift

Volumn 118, Issue 3-4, 2006, Pages 124-127

  Ers, Vincent ^a   Galant, Christine ^a   Malaise, Jacques ^a   Rahier, Jacques ^a   Daumerie, Chantal ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Axillary lymph node; Metastases; Thyroid carcinoma

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; AXILLARY LYMPH NODE; BONE SCINTISCANNING; CANCER RECURRENCE; CASE REPORT; ECHOGRAPHY; FEMALE; HUMAN; LABORATORY TEST; LYMPH NODE METASTASIS; PAPILLARY CARCINOMA; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; QUALITY OF LIFE; THYROID CARCINOMA;

AXILLA; BIOPSY, NEEDLE; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY DOSAGE; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33645689878     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-006-0533-1     Document Type: Article

References (12)

1. Haid A, Knauer M, Koberle-Wuhrer R, Wenzl E (2005) Sentinel node biopsy in breast cancer: techniques and indications. Wien Klin Wochenschr 117: 121-128
2. de Andrade JM, Marana HR, Sarmento Filho JM, Murta EF, Vellud MA, Bighetti S (1996) Differential diagnosis of axillary masses. Tumori 82: 596-599
3. Jaffer S, Goldfarb AB, Gold JE, Szporm A, Bleiweiss IJ (1995) Contralateral axillary lymph node metastasis as the first evidence of locally recurrent breast carcinoma. Cancer 75: 2875-2978
4. Koike K, Fujii T, Yanaga H, Nakagawa S, Yokoyama G, Yahara T, Hanzawa M, Kato S, Shirouzu K (2004) Axillary lymph node recurrence of papillary thyroid microcarcinoma: report of a case. Surg Today 34: 440-443
5. Schlumberger M, Parmentier C, de Vathaire F, Tubiana M (1997) Iodine-131 and External Radiation in the Treatment of Local and Metastatic Thyroid Cancer. In: Falk SA (ed) Thyroid disease: endocrinology, surgery, medicine and radiotherapy, 2nd edn. Lippincott-Raven, Philadelphia, p 612
6. Auersperg M, Us-Krsovec M, Petric G, Pogacnik, Besic N (1990) Results of combined modality treatment in poorly differentiated and anaplastic thyroid carcinoma. Wien Klin Wochenschr 1032: 267-270
7. Grunwald F, Kalicke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M, et al (1999) Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 26: 1547-1552
8. Wang W, Macapinlac H, Larson SM, Yeh SD, Akhurst T, Finn RD, et al (1999) [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic 131-I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab 84: 2291-2302
9. 131I-negative papillary thyroid carcinoma. J Nucl Med 41: 1010-1015
10. Muros MA, Llamas-Elvira JM, Ramirez-Navarro A, Acosta Gomez MJ, Rodriguez-Fernandez A, Muros T, et al (2000) Utility of fluorine-18- fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels. Am J Surg 179: 457-461
11. Schlüter B, Bohuslavizki KH, Beyer W, Plotkin M, Buchert R, Clausen M (2001) Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I Scan. J Nucl Med 42: 71-76
12. Wang W, Larson SM, Fazzari M, Tickoo SK, Kolbert K, Sgouros G, et al (2000) Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 85: 1107-1113